MCRB Competitors & Alternatives
Compare Seres Therapeutics Inc with similar stocks in the same industry
Biotechnology
MCRB
Main Stock$1.41
Tradestie Score
39
Market Cap
$179.47M
Revenue Growth
-0.9%
Analyst Upside
+1105.7%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FATE
Fate Therapeutics, Inc.
|
$1.35
|
$144.16M | - | 41 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.84
|
$133.50M | - | 29 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.75
|
$117.07M | - | 30 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$30.87
|
$110.20M | - | 41 | Compare |
|
MGNX
MacroGenics, Inc.
|
$2.30
|
$107.45M | - | 72 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.54
|
$97.42M | - | 50 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.21
|
$84.52M | - | 41 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.17
|
$67.94M | - | 46 | Compare |
|
KPTI
Karyopharm Therapeutics Inc.
|
$0.02
|
$53.85M | - | 48 | Compare |
|
SYRS
SYRS
|
- | - | - | - | Compare |
More MCRB Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry